There are numerous ways to run large language models such as DeepSeek, Claude or Meta's Llama locally on your laptop, including Ollama and Modular's Max platform. But if you want to fully control the ...

The premade Skills available through the Gemini sidebar in Chrome include ways to maximize protein in recipes or summarize YouTube videos. You can set up your own ...

What really happens after you hit enter on that AI prompt? WSJ’s Joanna Stern heads inside a data center to trace the journey and then grills up some steaks to show just how much energy it takes to ...

SNC’s site for E-4C work in Dayton, Ohio, has rapidly grown since the company won the competition in 2024. Credit: SNC The future backbone of U.S. nuclear command and control is taking shape in a set ...

This story is part of a Seattle Times focus on the affordability crisis in the Northwest. We explore the high cost of living and wealth disparities that shape our region; examine policies that impact ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

President Trump said there would likely be more American casualties as the U.S. military continues strikes against Iran. Photo: The White House When the U.S. military’s top general laid out the risks ...

AI expert Allie K. Miller demonstrates Anthropic's Claude Cowork, an AI agent tool that automates extensive business tasks. It analyzes documents, conducts research, builds interactive dashboards, and ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

In case you've faced some hurdles solving the clue, Software program run through a browser, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.